Back to top
more

Masimo (MASI)

(Delayed Data from NSDQ)

$139.94 USD

139.94
992,667

+4.27 (3.15%)

Updated Oct 8, 2024 04:00 PM ET

After-Market: $140.00 +0.06 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Masimo (MASI) O3 Regional Oximetry Device Gets FDA Nod

Masimo Corporation (MASI) recently announced the receipt of FDA 510(k) clearance for O3 regional oximetry device.

    Masimo (MASI) Beats on Q1 Earnings and Revenues, Guides Up

    Masimo Corp. (MASI) reported earnings of 57 cents per share in the first quarter of 2017, outperforming the Zacks Consensus Estimate of 54 cents and improving from the year-ago quarterly earnings of 53 cents.

      Zacks.com featured highlights: Ituran Location and Control, Molina Healthcare, WellCare Health Plans and Masimo

      Zacks.com featured highlights: Ituran Location and Control, Molina Healthcare, WellCare Health Plans and Masimo

        4 Top-Ranked Liquid Stocks for a Winning Portfolio

        Liquidity of a stock primarily indicates a company's capability to meet debt obligations by converting assets into liquid cash and equivalents.

          After ISRG Q1 Earnings, 3 Medical Instrument Stocks Looking Up

          While the Medical Instrument industry has been oscillating between hope and despair, let us take a look at three stocks which are expected to put up an impressive show this earnings season like Intuitive Surgical.

            Masimo (MASI) Launches Root Platform with Kite Trademark

            Irvine, CA-based Masimo Corporation (MASI) announced full market release of the Root monitoring platform with a Kite trademark (a supplementary display system).

              Obamacare Holds Ground: 3 Medical Device Stocks to Gain

              Republican leaders have failed to play their "Trump card" this time, courtesy of the pullback of the Republican healthcare bill, the American Health Care Act (ACHA), which was designed to repeal the Affordable Care Act (ACA) or Obamacare.

                Masimo (MASI) Up 20.6% Since Earnings Report: Can It Continue?

                Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                  3 Medical Device Stocks to Brave Policy Uncertainty

                  We believe stocks with strong fundamentals that also have a significant share of their business overseas may well brace themselves in the on-going conundrum. They will make lucrative additions to your portfolio.

                    Can The Uptrend Continue for Masimo (MASI)?

                    Investors certainly have to be happy with Masimo Corporation (MASI) and its short term performance

                      Masimo Announces Availability of RD SedLine Brain Sensors

                      Masimo Corporation (MASI) recently announced the availability of the RD SedLine EEG sensor, which can be used with the company???s flagship SedLine Brain Function Monitoring technology.

                        Is Masimo (MASI) a Great Growth Stock?

                        One company that might be well-positioned for future earnings growth is Masimo Corporation (MASI).

                          Sweta Killa headshot

                          Hit ETFs & Stocks from the Top Sector of February

                          Inside the best performing sector of February and their best ETFs & stocks.

                            Cooper (COO) to Report Q1 Earnings: Is a Surprise in Store?

                            The Cooper Companies Inc. (COO) is set to report first-quarter fiscal 2017 results after the market closes on Mar 2.

                              Follow Driehaus & Pick these 5 Best-Rated Momentum Stocks

                              Investors with high risk appetite may think of using the Driehaus strategy to boost their portfolio returns.

                                DexCom (DXCM) Q4 Earnings: What to Expect from the Stock?

                                DexCom, Inc. (DXCM) is set to report fiscal fourth-quarter 2017 results on Feb 28.

                                  Can Penumbra (PEN) Spring a Surprise this Earnings Season?

                                  Penumbra Inc. (PEN) is slated to release fourth-quarter 2016 results on Feb 28, after market close.

                                    Patterson Companies (PDCO) Q3 Earnings: What's in Store?

                                    Patterson Companies Inc. (PDCO) is set to report fiscal third-quarter 2017 results on Feb 23, before the opening bell.

                                      Medtronic (MDT) Q3 Earnings: Disappointment in the Cards?

                                      Ireland-based medical device major Medtronic plc (MDT) is slated to report its third-quarter fiscal 2017 earnings on Feb 21, before the opening bell.

                                        Masimo Gets CE Mark for RRp on MightySat Rx Pulse Oximeter

                                        Masimo Corporation (MASI) recently announced the receipt of CE mark approval for respiration rate measurement (RRp) on MightySat Rx fingertip pulse oximeter.

                                          Masimo to Launch Advanced Monitoring Technologies in India

                                          Masimo (MASI) announced that it will launch Advanced Monitoring Technologies in the Indian market.

                                            Masimo's (MASI) TFA-1 Forehead Sensor Gets FDA Approval

                                            Masimo Corporation (MASI) recently announced that its TFA-1 Single-Patient-Use Adhesive Forehead Sensor has received a 5I0(k) clearance from the U.S. FDA.

                                              Masimo (MASI) Hits 52-Week High on Solid Growth Prospects

                                              Share price of Irvine, CA-based Masimo Corporation (MASI) reached a new 52-week high of $63.45 on Dec 7, finally closing a tad lower at $62.17.